These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6408814)

  • 21. Viral hepatitis.
    Jackson MM
    Nurs Clin North Am; 1980 Dec; 15(4):729-46. PubMed ID: 6779265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of surgery in transmitting "post-transfusion hepatitis".
    Gallo C; Gaeta GB; Galanti B; Giusti G
    Eur J Epidemiol; 1986 Jun; 2(2):95-8. PubMed ID: 3095137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Viral hepatitis and blood transfusion].
    Larsen J; Hetland G; Skaug K; Maeland A
    Tidsskr Nor Laegeforen; 1991 Mar; 111(7):825-8. PubMed ID: 1850559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evolution of residual risk for HIV, HCV and HBV, from 1999 to 2010, in blood donations of the Centro Hospitalar S. João, EPE, Porto, Portugal].
    Koch C; Araújo F
    Acta Med Port; 2013; 26(4):371-6. PubMed ID: 24016646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-transfusion hepatitis: analysis of risk factors.
    Aach RD; Hollinger FB; Szmuness W; Mosley JW; Gitnick GL; Kahn RA; Stevens CE; Goodwin D; Weiner JM
    Acta Haematol Pol; 1980; 11(3):159-64. PubMed ID: 6778053
    [No Abstract]   [Full Text] [Related]  

  • 27. [Several aspects of the epidemiology of infectious and serum hepatitis at the present time].
    Tareev EM; Shatrov II; Mastiukova IuN
    Sov Med; 1977 Feb; (2):40-6. PubMed ID: 67648
    [No Abstract]   [Full Text] [Related]  

  • 28. Epidemiological and clinical aspects of hepatitis G virus infection in blood donors and immunocompromised recipients of HGV-contaminated blood.
    Heuft HG; Berg T; Schreier E; Künkel U; Tacke M; Schwella N; Hopf U; Salama A; Huhn D
    Vox Sang; 1998; 74(3):161-7. PubMed ID: 9595643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Post-transfusion hepatitis and its sequelae in the treatment of hemophilia].
    Schimpf K
    Behring Inst Mitt; 1983 Aug; (73):111-7. PubMed ID: 6433878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The role of the Ministry of Health in the prevention of diseases caused by blood transfusion].
    Wolpert Barraza E; Córdova MS; Robles Díaz G; Reyes López PA
    Gac Med Mex; 1994; 130(6):412-24. PubMed ID: 7557054
    [No Abstract]   [Full Text] [Related]  

  • 31. Transfusion-dependent thalassemia: viral complications (epidemiology and follow-up).
    de Montalembert M; Girot R; Mattlinger B; Lefrère JJ
    Semin Hematol; 1995 Oct; 32(4):280-7. PubMed ID: 8560285
    [No Abstract]   [Full Text] [Related]  

  • 32. [Viral hepatitis].
    Libert MH; Bourgeois N
    Acta Urol Belg; 1993; 61(1-2):247-55. PubMed ID: 7685979
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatitis C, other types of non-B parenteral hepatitis and blood transfusion.
    Dodd RY
    Dev Biol Stand; 1993; 81():35-40. PubMed ID: 8174817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Problem of mixed infections in viral hepatitis].
    Farber NA
    Ter Arkh; 1985; 57(2):68-71. PubMed ID: 3923643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. National strategy for the prevention and management of transfusion-associated hepatitis.
    Voigt MD; Bird AR; Kirsch RE; Kew MC; Aspinall S; Sims J
    S Afr Med J; 1996 Mar; 86(3):245-51. PubMed ID: 8658294
    [No Abstract]   [Full Text] [Related]  

  • 36. Viral hepatitis. 1. Clinical and laboratory aspects and epidemiology.
    Bryan JA
    Postgrad Med; 1980 Nov; 68(5):66-9, 72-6. PubMed ID: 6776509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transfusion-associated infections: 50 years of relentless challenges and remarkable progress.
    Perkins HA; Busch MP
    Transfusion; 2010 Oct; 50(10):2080-99. PubMed ID: 20738828
    [No Abstract]   [Full Text] [Related]  

  • 38. The epidemiology of viral hepatitis in the United States.
    Alter MJ; Mast EE
    Gastroenterol Clin North Am; 1994 Sep; 23(3):437-55. PubMed ID: 7989088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Viral hepatitis. What have we learned about risk factors and transmission?
    Becherer PR
    Postgrad Med; 1995 Jul; 98(1):65-8, 71-4. PubMed ID: 7603948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Transfusion-induced virus infections: how great is the risk?].
    Sibrowski W; Penner M; Kühnl P
    Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():4-9. PubMed ID: 8374287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.